Telesis Bio, Inc.
TBIO
$0.42
$0.1240.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 51.17% | -66.37% | -- |
| Total Depreciation and Amortization | -- | -- | 2.09% | 26.21% | -- |
| Total Amortization of Deferred Charges | -- | -- | -26.03% | -84.89% | -- |
| Total Other Non-Cash Items | -- | -- | -93.98% | 527.91% | -- |
| Change in Net Operating Assets | -- | -- | 186.86% | -403.03% | -- |
| Cash from Operations | -- | -- | 55.73% | -24.52% | 42.99% |
| Capital Expenditure | -- | -- | -99.21% | -240.54% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 88.97% | 129.14% | -- |
| Cash from Investing | -- | -- | 88.58% | 127.97% | -439.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 99.87% | -136,736.36% | -- |
| Issuance of Common Stock | -- | -- | -87.10% | 24.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -769.57% | -- |
| Cash from Financing | -- | -- | 99.82% | -14,772.28% | -100.38% |
| Foreign Exchange rate Adjustments | -- | -- | -146.15% | 181.25% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 156.73% | 45.83% | -225.64% |
